| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 46.196 | 82.060 | 90.695 | 115.914 | 130.081 | 151.079 | 188.204 |
| Total Income - EUR | - | - | 0 | 46.200 | 82.082 | 90.705 | 115.916 | 130.083 | 151.081 | 188.206 |
| Total Expenses - EUR | - | - | 511 | 18.740 | 24.626 | 28.124 | 50.895 | 61.381 | 65.241 | 77.168 |
| Gross Profit/Loss - EUR | - | - | -511 | 27.461 | 57.456 | 62.581 | 65.022 | 68.701 | 85.839 | 111.038 |
| Net Profit/Loss - EUR | - | - | -511 | 26.999 | 56.638 | 61.749 | 63.864 | 67.397 | 84.329 | 105.386 |
| Employees | - | - | 0 | 2 | 2 | 2 | 3 | 3 | 4 | 4 |
Check the financial reports for the company - Ruxbiomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 27 | 569 | 558 | 2.483 | 10.146 | 21.627 | 14.533 | 11.930 |
| Current Assets | - | - | 382 | 31.246 | 57.165 | 61.550 | 58.116 | 112.556 | 79.887 | 207.605 |
| Inventories | - | - | 12 | 11 | 0 | 932 | 487 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 67.537 | 35.567 | 102.568 |
| Cash | - | - | 370 | 31.235 | 57.165 | 60.618 | 57.629 | 45.020 | 44.320 | 105.037 |
| Shareholders Funds | - | - | -467 | 26.540 | 56.680 | 61.832 | 63.945 | 67.478 | 84.410 | 105.466 |
| Social Capital | - | - | 44 | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | 876 | 5.275 | 1.043 | 2.201 | 4.373 | 66.705 | 10.011 | 114.069 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ruxbiomed S.r.l.